Paraoxonase 1 (PON1) is present in postprandial chylomicrons

Atherosclerosis

Volumn 180, Issue 1, 2005, Pages 55-61

  Fuhrman, Bianca ^a   Volkova, Nina ^a   Aviram, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Chylomicrons; HDL; LDL; Lipid peroxides; Paraoxonases 1 (PON1); Postprandial state; VLDL

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CHYLOMICRON; COPPER; HIGH DENSITY LIPOPROTEIN; ION; LIPID PEROXIDASE; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CARBOHYDRATE DIET; CASE REPORT; DIET RESTRICTION; HUMAN; HYDROLYSIS; HYPERLIPOPROTEINEMIA TYPE 1; LIPID DIET; MALE; OXIDATION; PATIENT; POSTPRANDIAL STATE; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

EID: 17044372764     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.12.009     Document Type: Article

References (30)

1. B.N. La Du Structural and functional diversity of paraoxonases Nature Med 2 1996 1186 1187
2. B.N. La Du, S. Adkins, C.L. Kuo, and D. Lipsig Studies on human serum paraoxonase/arylesterase Chem Biol Interact 87 1993 25 34
3. H.L. Li, D.P. Liu, and C.C. Liang Paraoxonase gene polymorphisms, oxidative stress, and diseases J Mol Med 81 2003 766 779
4. M. Aviram, E. Hardak, and J. Vaya Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities Circulation 101 2000 2510 2517
5. M. Aviram, M. Rosenblat, C.L. Bisgaier, R.S. Newton, S.L. Primo-Parmo, and B.N. La Du Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase J Clin Invest 101 1998 1581 1590
6. A.D. Watson, J.A. Berliner, and S.Y. Hama Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest 96 1995 2882 2891
7. M.I. Mackness, S. Arrol, C. Abbott, and P.N. Durrington Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase Atherosclerosis 104 1993 129 135
8. O. Rozenberg, M. Rosenblat, R. Coleman, D.M. Shih, and M. Aviram Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice Free Radic Biol Med 34 2003 774 784
9. M.I. Mackness, B. Mackness, P.N. Durrington, P.W. Connelly, and R.A. Hegele Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins Curr Opin Lipidol 7 1996 69 76
10. R.C. Sorenson, C.L. Bisgaier, M. Aviram, C. Hsu, S. Billecke, and B.N. La Du Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity Arterioscler Thromb Vasc Biol 19 1999 2214 2225
11. R.W. James, and S.P. Deakin The importance of high density lipoproteins for paraoxonase-1 secretion, stability and activity Free Radic Biol Med 37 2004 1986 1994
12. M. Aviram, M. Rosenblat, and S. Billecke Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants Free Radic Biol Med 26 1999 892 904
13. M. Mackness, A. Boullier, and N. Hennuyer Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits Biochem Biophys Res Commun 269 2000 232 236
14. M.S. van der Gaag, A. van Tol, and L.M. Scheek Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men Atherosclerosis 147 1999 405 410
15. M. Aviram, L. Dornfeld, and M. Rosenblat Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice Am J Clin Nutr 71 2000 1062 1076
16. G.P. Jarvik, N.T. Tsai, and L.A. McKinstry Vitamin C and E intake is associated with increased paraoxonase activity Arterioscler Thromb Vasc Biol 22 2002 1329 1333
17. W.H. Sutherland, R.J. Walker, S.A. De Jong, A.M. Van Rij, V. Phillips, and H.L. Walker Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat Arterioscler Thromb Vasc Biol 19 1999 1340 1347
18. A.J. Wallace, W.H. Sutherland, J.I. Mann, and S.M. Williams The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes Eur J Clin Nutr 55 2001 951 958
19. M. Aviram Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients Biochem Med 30 1983 111 118
20. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
21. M. Aviram, and J. Vaya Markers for low-density lipoprotein oxidation Methods Enzymol 335 2001 244 256
22. K.N. Gan, A. Smolen, H.W. Eckerson, and B.N. La Du Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities Drug Metab Dispos 19 1991 100 106
23. C.J. Ng, D.J. Wadleigh, and A. Gangopadhyay Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein J Biol Chem 276 2001 44444 44449
24. P.W. Connelly, G.F. Maguire, and D.I. Draganov Separation and quantitative recovery of mouse serum arylesterase and carboxylesterase activity J Lipid Res 45 2004 561 566
25. G.S. Getz, and C.A. Reardon Paraoxonase, a cardioprotective enzyme: continuing issues Curr Opin Lipidol 15 2004 261 267
26. S.L. Primo-Parmo, R.C. Sorenson, J. Teiber, and B.N. La Du The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family Genomics 33 1996 498 507
27. M.I. Mackness, S. Arrol, and P.N. Durrington Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein FEBS Lett 286 1991 152 154
28. B. Fuhrman, A. Partoush, and M. Aviram Acetylcholine esterase protects LDL against oxidation Biochem Biophys Res Commun 322 2004 974 978
29. S. Bhakdi, K.J. Lackner, S.R. Han, M. Torzewski, and M. Husmann Beyond cholesterol: the enigma of atherosclerosis revisited Thromb Haemost 91 2004 639 645
30. N. Stadler, R.A. Lindner, and M.J. Davies Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper Arterioscler Thromb Vasc Biol 24 2004 949 954